Advanced Technology Ventures

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

Business Model:

Revenue: $15.5M

Employees: 11-50

Rankings

Detailed Advanced Technology Ventures Information

Geographic Data

Advanced Technology Ventures headquarters map

Address: 485 Ramona St

City: Palo Alto

State: CA

Zip: 94301

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

5,440,519Website Global Rank

1,705Website Monthly Traffic

Twitter Followers

Description

[Advanced Technology Ventures](http://www.atvcapital.com) (ATV) is a bi-coastal venture capital firm that focuses on communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices and cleantech.

Contact Phone:
+16503218601

Contact Email:

Announced Date Company Transaction Money Raised
4/2009 Nuventix Series C 0
4/2000 Sound Vision Series A 0
9/2002 iConverse Series C 6M
8/1998 Avolent Series B 10M
4/2014 Nuvaira Series D 42M
1/2014 PowerVision Series D 0
4/2013 Solar Junction Venture Round 8.1M
1/1999 Tripwire Series A 2.4M
4/2013 Planful Venture Round 6.5M
3/2012 GluMetrics Venture Round 13.3M
6/2003 GI Dynamics Series A 4.1M
6/2000 WorldStreet Venture Round 0
3/2005 NeoScale Systems Series D 12M
3/2003 Hypnion Series B 47.5M
11/1999 Grassroots Series A 3.4M
7/2003 Tripwire Series D 8.3M
9/1999 MicroVention Series B 7.5M
8/2010 NeuroVista Venture Round 16.5M
1/2008 Integrated Media Measurement (IMMI) Series C 25M
1/2004 deNovis Series C 22M
10/2001 deNovis Series B 43.8M
3/2004 Precision I/O, Inc. Series A 10M
3/2002 Tripwire Series C 0
10/1998 Linx Communications Series A 5.1M
2/2005 Five Prime Therapeutics Series C 45M
12/2006 SUB ONE TECHNOLOGY Series B 7M
8/2000 CaseCentral Series B 0
7/2008 Qumu Post-IPO Equity 0
3/2017 Oasys Water Series B 4M
2/2013 Astria Therapeutics Venture Round 9M
10/2013 Calithera Biosciences Series D 35M
12/2012 Calithera Biosciences Series C 2M
3/2004 Peakstone Series D 5M
5/2000 Express Action Series A 14M
1/2013 Planful Series D 17M
5/2009 Planful Series B 8.7M
11/2001 Peakstone Series C 12M
2/2008 PolyRemedy Series B 25M
6/2006 Silicor Materials Series A 9M
5/2014 Evergage Series A 4M
12/2010 Astria Therapeutics Series A 14.5M
6/2004 Emphasys Medical Series D 27.5M
3/2009 Ardian Series C 47M
9/2008 Valeritas Series A 50M
12/2000 Innovance Series A 75M
8/2006 Sanovi Technologies Series B 6.1M
7/2001 UpShot Corporation Series E 17M
9/2012 Nuvaira Series B 10.6M
2/2013 Gynesonics Series D 21M
7/2015 Gynesonics Venture Round 43M
1/2007 Gynesonics Series B 16.5M
3/2002 Polaris Networks Series B 52M
3/2008 Aperio Technologies Series C 20M
5/2007 Aperio Technologies Series C 10.6M
11/2014 Planful Series E 25M
1/2016 Cedexis Series B 0
12/2000 Alfalight Series B 28M
5/2008 Solar Junction Series A 18M
1/2003 Visage Mobile Series A 5M
12/2000 Circe Biomedical Private Equity Round 28M
9/2003 Noosh Series A 5.1M
8/2007 Helixis Series A 10M
4/2016 Second Genome Series B 51M
5/2012 Evergage Seed Round 2M
11/1999 NewMediary Series B 5M
3/2003 OneChannel Series D 8.5M
3/2000 UpShot Corporation Venture Round 26M
10/2007 Zeltiq Aesthetics Series B 20.3M
5/2000 UBUBU, Inc. Series B 7M
10/2000 Optobionics Corporation Venture Round 4M
2/2009 Oasys Water Series A 10M
6/2004 Acme Packet Series C 1.4M
11/1999 Noosh Private Equity Round 0
7/2011 PowerVision Series C 24M
6/2000 SpectraSwitch Series B 18.1M
5/2007 NeuroVista Series B 33.8M
5/2004 Plexxikon Series B 0
8/2018 Actifio Series F 100M
9/2010 Actifio Series B 16M
12/2011 Actifio Series C 33.5M
1/2000 FactCity Series A 5.5M
7/2006 GluMetrics Series B 9M
1/2004 Intransa Series C 8M
7/2000 Linx Communications Series B 10.5M
7/1998 Avolent Series A 5M
11/2005 GreatPoint Energy Series A 7M
3/2003 Packet Design Series A 14.3M
10/1999 DirectAg.com Venture Round 12.6M
2/2013 Nuvaira Series C 10M
3/2005 XTENT Series C 25M
7/2006 Engage Post-IPO Equity 5M
9/2007 Apprion Series B 12M
11/2003 Percardia Series D 23.5M
1/2014 Aquion Energy Series D 20M
3/2008 Coskata Series B 19.5M
4/2000 Endurance International Group Venture Round 11.5M
11/2012 Modria Seed Round 1.3M
6/2008 [x+1] Series A 0
2/2002 Wave7 Optics Series B 23M
1/2003 CaseCentral Series D 2.2M
8/2013 Coskata Debt Financing 3M
5/2000 Opthos Series A 14.9M
9/2014 Ivantis Series B 25M
5/2003 Redline Networks Series C 0
1/2003 Intransa Series B 6M
9/2010 Qumu Post-IPO Debt 0
7/2000 Peakstone Series B 15M
7/2004 Wave7 Optics Venture Round 6M
8/2001 CaseCentral Series C 5M
5/2014 EndoGastric Solutions Series G 0
6/2001 CeLight Series B 32.5M
9/2008 Anagran Series D 0
1/2008 Anagran Series C 12M
3/2008 Cenzic Series D 10M
11/2013 Astria Therapeutics Series B 32.4M
6/2010 Planful Series C 15M
12/2007 PowerVision Series B 20M
2/2019 Nuvaira Equity 79M
2/2002 Innovance Series B 0
6/2011 Evergage Angel Round 250k
7/2007 NeoScale Systems Series F 8M
8/2004 Intransa Series D 24M
7/2014 Gynesonics Debt Financing 28.4M
1/2018 Gynesonics Private Equity Round 75M
8/2003 Compassoft Series A 4M
9/2008 Proteolix Series C 79M
6/2003 Vivato Series C 44.5M
3/2012 EndoGastric Solutions Series G 10.9M
2/2002 Intransa Venture Round 10M
6/2010 Zeltiq Aesthetics Series D 25M
1/2005 Visage Mobile Series C 22.8M
8/2013 Rive Technology Series D 0
11/2008 CombineNet Series E 9.9M
9/2002 SpectraSwitch Series C 7.5M
8/2012 QuickPay Seed Round 3.5M
6/2011 PolyRemedy Series C 20M
8/2001 Onix Microsystems Series C 95M
3/2008 Handango Series C 0
4/2012 EndPlay Series C 21.5M
5/2004 e-Security Series C 5M
1/2001 Black Pearl Series C 14.3M
1/2011 [x+1] Series B 0
1/2002 SpectraSwitch Series B 6M
6/2018 EndoGastric Solutions Series I 0
11/2008 Silicor Materials Series B 101.8M
8/2000 OneChannel Series C 0
9/2006 Handango Series B 60.5M
2/2000 Grassroots Series B 0
10/1999 Decide.com Series B 16.5M
4/2005 ChannelAdvisor Series B 18M
11/2006 Ardian Series B 10.1M
7/2011 Verastem Oncology Series B 32M
4/2004 Omneon Venture Round 0
9/2008 ChannelAdvisor Series D 0
2/2012 Solar Junction Series D 19.2M
6/2013 Second Genome Series A 0
9/2011 Valeritas Series C 150M
12/2015 EndoGastric Solutions Venture Round 0
3/2002 Bermai Series A 15M
6/2010 Altura Medical Series A 20M
6/2003 Bermai Series B 12M
12/2001 Bermai Series A 12M
7/2005 Cenzic Series C 15M
6/2000 Avolent Series C 30M
7/2001 Redline Networks Series B 10M
12/2005 Aperio Technologies Venture Round 12M
10/2012 Fuze, an 8x8 company Series A 16.5M
12/2002 Striva Series B 12.7M
6/2000 Onix Microsystems Series B 35.5M
5/2007 Compassoft Series B 7M
6/2010 Acceleron Pharma Venture Round 10.3M
10/2001 College Publisher, Inc. Series B 8.5M
12/2002 Alfalight Series C 15M
10/2003 Critical Therapeutics,Inc. Series B 56M
12/2011 Astria Therapeutics Series A 8M
4/2010 Astria Therapeutics Series A 39M
6/2009 Silicor Materials Series C 60M
12/2010 Rive Technology Series C 25M
9/2003 Wave7 Optics Series C 30.5M
8/2007 Rive Technology Series A 8.4M
3/2014 Actifio Series E 100M
8/2000 Annuncio Software Venture Round 36M
7/1999 Omneon Series B 0
12/1999 OneChannel Series B 12M
3/2000 Annuncio Software Venture Round 0
6/2008 Wakonda Technologies Series A 3.2M
3/2008 Hydra Biosciences Series C 34M
1/2001 CytoLogix Series B 0
2/2004 CombineNet Series C 12M
9/2000 deNovis Series A 32M
7/2010 Calithera Biosciences Series A 40M
3/2015 Thrasos Series D 21M
10/2012 Thrasos Series C 35M
8/2010 EndoGastric Solutions Series F 0
6/2009 EndoGastric Solutions Venture Round 3.8M
11/2005 Portola Pharmaceuticals Series B 46M
6/2003 EndoGastric Solutions Series A 5M
9/2004 EndoGastric Solutions Series B 12M
8/2006 Acceleron Pharma Series B 30M
12/2005 Hypnion Series B 0
7/2014 Valeritas Series D 45M
1/2009 Hydra Biosciences Series D 22M
3/2009 GI Dynamics Series C 0
12/1997 Endius Series B 0
5/2004 GI Dynamics Series B 0
11/2011 Calithera Biosciences Venture Round 4M
12/2005 Visage Mobile Series D 30M
1/2004 Hydra Biosciences Series B 0
11/2001 Opthos Series B 21.6M
11/2008 Coskata Series C 40M
7/2010 Coskata Series D 23.7M
8/2008 GluMetrics Series C 20.1M
5/2007 ChannelAdvisor Series C 30M
7/2002 Hydra Biosciences Series A 9.3M
3/2010 Solar Junction Series C 13.3M
11/2005 Anagran Series B 14M
10/2007 Acceleron Pharma Series C 31M
1/2003 Ardais Corporation Series C 14M
1/2006 WildTangent Venture Round 13M
4/2013 Aquion Energy Series D 35M
9/2011 Aquion Energy Venture Round 30M
10/2013 Fuze, an 8x8 company Series B 10M
6/2000 WorldChain Series A 10.2M
3/2005 Nominum Series D 16M
2/2000 Tripwire Series B 9M
8/2008 AltaRock Energy Series B 26.3M
9/2006 Liquid Engines Series C 5.5M
2/2004 Liquid Engines Series C 9.2M
6/2008 Rive Technology Series B 14M
1/2013 GluMetrics Debt Financing 5.6M
5/2003 TranS1 Series B 0
9/1987 Spectra Vision Venture Round 150k
3/1988 Spectra Vision Venture Round 100k
2/2006 CombineNet Series D 7.7M
8/2011 Cedexis Series A 11.2M
1/2006 Apprion Series A 7.5M
1/2006 Browster Series A 5.8M
7/2005 Ceterus Networks Series D 5.3M
1/1997 Endius Series A 3.5M
3/2006 Zeltiq Aesthetics Series A 7.5M
11/1999 UBUBU, Inc. Venture Round -
5/2004 WildTangent Series D 0
11/2009 EndoGastric Solutions Series E 0
10/2009 EndoGastric Solutions Venture Round 0
6/2012 EndoGastric Solutions Venture Round 0
4/2012 EndoGastric Solutions Venture Round 0
10/2000 Ardais Corporation Series A 9M
2/2019 Nuvaira Series E 0
8/2018 Actifio Series F 0
6/2018 EndoGastric Solutions Series I 0
1/2018 Gynesonics Private Equity Round 0
3/2017 Oasys Water Series B 0
4/2016 Second Genome Series B 0
1/2016 Cedexis Series B 0
12/2015 EndoGastric Solutions Venture Round 0
7/2015 Gynesonics Venture Round 0
3/2015 Thrasos Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research